Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Variable is a biotechnology company leveraging generative artificial intelligence and high-throughput experimental platforms to design novel protein therapeutics. The company's platform focuses on creating programmable proteins that can be precisely tuned for specific biological functions and therapeutic targets. By integrating computational design with rapid synthesis and testing, Variable aims to accelerate the development of next-generation biologics across various disease areas. The company was founded by experts in protein engineering and machine learning to overcome the limitations of traditional protein discovery. Variable's approach treats protein sequence space as a searchable and programmable domain, allowing for the creation of binders and enzymes with optimized properties.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on variable biotechnology.